Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Igenbio is a bioinformatics company specializing in the analysis of microbial genomes and metabolic engineering. The company's core offering is the ERGO genome analysis platform, a web-based system that integrates genomic data with metabolic reconstruction and pathway analysis tools. Igenbio provides services to the pharmaceutical, agricultural, and industrial biotechnology sectors, helping clients identify novel drug targets and optimize microbial strains for production. Their expertise spans genome sequencing, functional annotation, and comparative genomics to support research and development in life sciences. The ERGO platform contains a vast proprietary database of curated genomes, facilitating rapid discovery and analysis for researchers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Igenbio.